Causeway Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Latest Deal Type
  • Seed
  • Investors
  • 3

Causeway Therapeutics General Information

Description

Developer of novel therapies designed to treat common musculoskeletal diseases. The company's therapies are based on identifying the molecular mechanism that causes damaged tendons to develop tendinopathy caused by loss of microRNA and controls the repair process by their pharmaceutical product that mimics this natural microRNA and cures them, enabling patients to reduce the pain of damaged and weakened tendons in a faster and advanced way.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Imaging Centre of Excellence Building
  • Queen Elizabeth University Hospital
  • Glasgow G51 4TF
  • Scotland, United Kingdom
+44 0141 000 0000

Causeway Therapeutics Timeline

2018201920202021
Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Causeway Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 07-Feb-2019 00.00 Completed Generating Revenue
2. Grant 31-May-2018 00.000 00.00 Completed Generating Revenue
1. Seed Round 03-Aug-2017 $1.3M $1.3M 00.000 Completed Generating Revenue
To view Causeway Therapeutics’s complete valuation and funding history, request access »

Causeway Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series Preferred 0,000 00.000000 0000.00 0000.00 00 0000.00 000
To view Causeway Therapeutics’s complete cap table history, request access »

Causeway Therapeutics Executive Team (4)

Name Title Board Seat Contact Info
Derek Gilchrist Co-Founder, Chief Executive Officer, Chief Scientific Officer, Managing Director & Board Member
David Armour Chief Financial Officer
Susan Kitson Chief Research Officer
Neal Millar Chief Medical Officer & Co-Founder
To view Causeway Therapeutics’s complete executive team members history, request access »

Causeway Therapeutics Board Members (5)

Name Representing Role Since
Christopher Jones Self Board Member 000 0000
Declan Doogan MD Self Chairman 000 0000
Derek Gilchrist Causeway Therapeutics Co-Founder, Chief Executive Officer, Chief Scientific Officer, Managing Director & Board Member 000 0000
Neal Juster Ph.D Self Board Member 000 0000
Neil Gibson Causeway Therapeutics Board Member 000 0000
To view Causeway Therapeutics’s complete board members history, request access »

Causeway Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innovate UK Government 000 0000 000000 0
Mediqventures Venture Capital Minority 000 0000 000000 0
Scottish Enterprise Venture Capital Minority 000 0000 000000 0
To view Causeway Therapeutics’s complete investors history, request access »